(PDFS) PDF Solutions - Overview
Stock: Software, Hardware, Analytics, Connectivity, Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 54.2% |
| Relative Tail Risk | -1.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.25 |
| Alpha | -19.23 |
| Character TTM | |
|---|---|
| Beta | 1.584 |
| Beta Downside | 1.221 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.53% |
| CAGR/Max DD | -0.06 |
Description: PDFS PDF Solutions December 25, 2025
PDF Solutions, Inc. (NASDAQ:PDFS) develops proprietary software, IP, and measurement hardware that help semiconductor manufacturers collect, analyze, and act on data across the entire product life-cycle. Its addressable market spans the United States, Japan, China, Taiwan, and other global fabs.
The Exensio suite includes Manufacturing Analytics (a database-driven yield-analysis engine), Process Control (real-time failure detection and alarm management), Test Operations (automated data capture for wafer-test), and Assembly Operations (linking assembly, packaging, and characterization data). Complementary offerings such as the Sapience Manufacturing Hub provide enterprise-level connectivity, while Design-For-Inspection (DFI) tools-eProbe, on-chip instruments, and the Characterization Vehicle-enable inline electrical testing without physical contact.
From a market-driven perspective, PDF Solutions benefits from two secular trends: (1) the ongoing shift toward data-centric “smart fab” operations, which the McKinsey Global Institute estimates will drive $30 billion in incremental equipment spend by 2027, and (2) the acceleration of advanced-node adoption (5 nm and below), which raises the premium on yield-improving analytics. In FY 2024 the company reported ~ $200 million in revenue with a gross margin of roughly 68 %, and its recurring SaaS contracts now represent about 35 % of total revenue-both metrics that suggest a growing, higher-margin recurring base.
For a deeper dive into PDF Solutions’ valuation dynamics, consider exploring ValueRay’s analyst notes, which break out the firm’s forward-looking cash-flow assumptions in a transparent, data-first format.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -53.0k TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -3.67 > 1.0 |
| NWC/Revenue: 38.72% < 20% (prev 78.39%; Δ -39.67% < -1%) |
| CFO/TA 0.02 > 3% & CFO 8.32m > Net Income -53.0k |
| Net Debt (37.9m) to EBITDA (10.6m): 3.57 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.6m) vs 12m ago 1.31% < -2% |
| Gross Margin: 71.18% > 18% (prev 0.70%; Δ 7048 % > 0.5%) |
| Asset Turnover: 57.92% > 50% (prev 55.48%; Δ 2.45% > 0%) |
| Interest Coverage Ratio: 0.46 > 6 (EBITDA TTM 10.6m / Interest Expense TTM 8.44m) |
Altman Z'' -0.11
| A: 0.20 (Total Current Assets 146.1m - Total Current Liabilities 66.1m) / Total Assets 406.4m |
| B: -0.23 (Retained Earnings -94.6m / Total Assets 406.4m) |
| C: 0.01 (EBIT TTM 3.87m / Avg Total Assets 356.9m) |
| D: -0.68 (Book Value of Equity -96.6m / Total Liabilities 142.0m) |
| Altman-Z'' Score: -0.11 = B |
Beneish M -1.74
| DSRI: 1.63 (Receivables 92.0m/46.7m, Revenue 206.7m/170.5m) |
| GMI: 0.98 (GM 71.18% / 69.83%) |
| AQI: 2.11 (AQ_t 0.45 / AQ_t-1 0.21) |
| SGI: 1.21 (Revenue 206.7m / 170.5m) |
| TATA: -0.02 (NI -53.0k - CFO 8.32m) / TA 406.4m) |
| Beneish M-Score: -1.74 (Cap -4..+1) = CCC |
What is the price of PDFS shares?
Over the past week, the price has changed by -8.73%, over one month by -9.50%, over three months by +5.75% and over the past year by +2.58%.
Is PDFS a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PDFS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.8 | 19.5% |
| Analysts Target Price | 34.8 | 19.5% |
| ValueRay Target Price | 29 | -0.4% |
PDFS Fundamental Data Overview February 03, 2026
P/S = 6.0883
P/B = 4.7601
P/EG = 2.37
Revenue TTM = 206.7m USD
EBIT TTM = 3.87m USD
EBITDA TTM = 10.6m USD
Long Term Debt = 65.3m USD (from longTermDebt, last quarter)
Short Term Debt = 4.21m USD (from shortTermDebt, last quarter)
Debt = 73.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 37.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.30b USD (1.26b + Debt 73.8m - CCE 35.9m)
Interest Coverage Ratio = 0.46 (Ebit TTM 3.87m / Interest Expense TTM 8.44m)
EV/FCF = -63.22x (Enterprise Value 1.30b / FCF TTM -20.5m)
FCF Yield = -1.58% (FCF TTM -20.5m / Enterprise Value 1.30b)
FCF Margin = -9.92% (FCF TTM -20.5m / Revenue TTM 206.7m)
Net Margin = -0.03% (Net Income TTM -53.0k / Revenue TTM 206.7m)
Gross Margin = 71.18% ((Revenue TTM 206.7m - Cost of Revenue TTM 59.6m) / Revenue TTM)
Gross Margin QoQ = 72.27% (prev 71.22%)
Tobins Q-Ratio = 3.19 (Enterprise Value 1.30b / Total Assets 406.4m)
Interest Expense / Debt = 1.68% (Interest Expense 1.24m / Debt 73.8m)
Taxrate = 38.33% (2.52m / 6.58m)
NOPAT = 2.39m (EBIT 3.87m * (1 - 38.33%))
Current Ratio = 2.21 (Total Current Assets 146.1m / Total Current Liabilities 66.1m)
Debt / Equity = 0.28 (Debt 73.8m / totalStockholderEquity, last quarter 264.4m)
Debt / EBITDA = 3.57 (Net Debt 37.9m / EBITDA 10.6m)
Debt / FCF = -1.85 (negative FCF - burning cash) (Net Debt 37.9m / FCF TTM -20.5m)
Total Stockholder Equity = 254.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.01% (Net Income -53.0k / Total Assets 406.4m)
RoE = -0.02% (Net Income TTM -53.0k / Total Stockholder Equity 254.2m)
RoCE = 1.21% (EBIT 3.87m / Capital Employed (Equity 254.2m + L.T.Debt 65.3m))
RoIC = 0.78% (NOPAT 2.39m / Invested Capital 305.3m)
WACC = 11.16% (E(1.26b)/V(1.33b) * Re(11.75%) + D(73.8m)/V(1.33b) * Rd(1.68%) * (1-Tc(0.38)))
Discount Rate = 11.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.03%
Fair Price DCF = unknown (Cash Flow -20.5m)
EPS Correlation: 32.44 | EPS CAGR: -37.24% | SUE: -1.83 | # QB: 0
Revenue Correlation: 93.32 | Revenue CAGR: 18.85% | SUE: 1.15 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.21 | Chg30d=-0.030 | Revisions Net=-3 | Analysts=3
EPS next Year (2026-12-31): EPS=1.07 | Chg30d=-0.022 | Revisions Net=+1 | Growth EPS=+25.8% | Growth Revenue=+19.3%